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Abstract
Taurine (T) was first noted as beneficial for stroke and cardiovascular diseases (CVD) prevention in genetic rat mod-
els, stroke-prone spontaneously hypertensive rats (SHRSP). The preventive mechanisms of T were ascribed to sym-
pathetic modulation for reducing blood pressure (BP) and anti-inflammatory action. Recent epidemiological surveys
revealed the involvement of inflammatory mediators in the pathogenesis of stroke and also atherosclerosis for
which T was proven to be effective experimentally. Arterio-lipidosis prone rats, a substrain of SHRSP selectively
bred for higher reactive hypercholesterolemia, quickly develop not only arterial fat deposition but also fatty liver
which could be attenuated by dietary T supplementation. CARDIAC (CVD and Alimentary Comparison) Study was a
WHO-coordinated multi-center epidemiological survey on diets and CVD risks and mortalities in 61 populations.
Twenty-four-hour urinary (24U) T was inversely related significantly with coronary heart disease mortality. Higher
24U-T excreters had significantly lower body mass index, systolic and diastolic BP, total cholesterol (T-Cho), and
atherogenic index (AI: T-Cho/high density lipoprotein-cholesterol) than lower T excreters. T effects on CVD risks
were intensified in individuals whose 24U-T and -magnesium (M) excretions were higher. Furthermore, higher Na
excreters with higher heart rate whose BP were significantly higher than those with lower heart rate were divided
into two groups by the mean of 24U-T, high and low T excreters. Since the former showed significantly lower BP
than the latter, T may beneficially affect salt-sensitive BP rise. Included among the typical 61 populations, were
Guiyang, China or St. John’s, Newfoundland, Canada where in which the means of both 24U-T and -M were high
or low, respectively. The former and the latter had low and high CVD risks, respectively. Australian Aboriginals living
at the coastal area in Victoria were supposed to eat T- and M-rich bush and sea foods and be free from CVD 200
years ago, but they presently have nearly the highest CVD risks indicating that T- and/or M-containing seafood,
vegetables, fruits, nuts, milk, etc, similar to prehistoric hunters’ and gatherers’ food should be good for CVD preven-
tion. The preventive effects of T, good for health and longevity, first noted experimentally, were also proven epide-
miologically in humans.
Introduction
The health effects of taurine (T), “a wonder molecule”,
was first noted in our genetic rat models for hyperten-
sion (Spontaneously Hypertensive Rats: SHR) [1,2] and
stroke (Stroke-prone SHR: SHRSP) [3,4] and are now
being confirmed epidemiologically by our WHO-
coordinated Cardiovascular Diseases and Alimentary
Comparison (CARDIAC) Study covering 61 populations
in the world [5-8]. Advances in extensive studies on
experimental models indicate that T is preventive
against hypertension [9], stroke and atherosclerotic
arterial diseases [10-12]. T is also expected to be effec-
tive for the prevention of nonalcoholic steato-hepatitis
(NASH) increasing now in developed countries [13].
Accumulating evidence from CARDIAC Study indicates
that common T intakes reduce cardiovascular disease
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nese [12] which have the lowest coronary heart disease
(CHD) mortality in developed countries. Furthermore,
the recent health study has revealed that CHD risks are
definitely lower in the individuals and populations with
higher 24-hour urinary (24U)-T and -magnesium (M)
excretions [14].
1) Taurine (T) and prevention of cardiovascular diseases
(CVD)
Since SHRSP was established as a genetic model devel-
oping stroke, extensive nutritional and pharmacological
studies have been conducted experimentally [7,9,10,15].
Our experiments to feed SHRSP on high or low fish
protein diets with or without 1 % salt in drinking water
first demonstrated that fish protein rich in T attenuated
salt-induced severe hypertension and decreased stroke
incidence from 80% down to 10% [4,15]. High fish pro-
tein diet with low salt in drinking water was proven to
be most effective to reduce stroke down to 0%. We
further investigated the effects of several amino acids
contained in fish protein in SHRSP and confirmed that
T is effective for reducing blood pressure (BP) in
SHRSP [9]. Among our experiments to prove the effect
of various nutrient and amino acid supplementations on
BP and stroke incidence in SHRSP, sulfur amino acids,
such as T and methionine, were effective on the reduc-
tion of BP and stroke incidence [6]. Other than sulfur
amino acids reducing BP, lysine had no effect on BP but
was also effective for the prevention of stroke. We spec-
ulate therefore that enough amino acid supply to the
vascular wall also might be protective against stroke
[6,15].
Therefore, we further analyzed the nutritional
mechanisms of stroke in SHRSP and also in humans.
The common predilection site of stroke is the basal
ganglia which are fed through perforating arteries
branching recurrently from the cerebro-basal arteries.
Blood flow through such recurrent arteries is reduced
hemorheologically in hypertension, and thus vascular
damage develops due to the reduced blood supply to
these arterial walls [15,16]. Anatomically the vascular
wall of these recurrent arterial branches should receive
nutritional supply only from the blood stream inside the
vessel through the blood-brain barrier, whereas the cere-
bro-basal arteries receive nutritional supply through
capillaries around the vascular wall, (“vasa vasorum”).
Our morphological electron microscopic studies in
1980’s for the first time demonstrated that vascular
damages start at the outer layer of the vascular smooth
muscle cells located at the furthest site from the vascu-
lar lumen [15,16]. Moreover, we proved that macro-
phages were activated in response to the vascular
d a m a g e st h a to c c u r r e di n i t i ally at the outer layer of
perforating arteries in the brain. Such nutritional vascu-
lar damages are followed by inflammatory reactions. At
the advanced stage vascular damages occur at the inner
layer of cerebral vessels which leads to vascular wall
rupture that causes cerebral hemorrhage or to thrombo-
sis inside the damaged blood vessels that causes cerebral
infarction [15,16]. These pathological processes were
further confirmed in human autopsy materials by an
immuno-histochemical technique [17] in which macro-
phages were recruited to cause and heal cerebro-vascu-
lar damages. Vascular smooth muscle cells initially
remained intact near the intima close to the vascular
lumen as in SHRSP. Therefore, we can speculate that
the activation of macrophages and other inflammatory
cells are supposed to further damage cerebral arteries,
causing severe vascular lesions such as angio-necrosis.
However, when these inflammatory cells contain much
T from nutrients, T-chloramine neutralizes the adverse
action of radicals produced from chlor [18] and may
help vascular cells survive or regenerate to repair the
wall [19].
After our demonstration of the importance of inflam-
mation in stroke in rat models, the pathogenic concept
of stroke as well as atherosclerosis in humans has also
changed greatly [20]. High sensitive C-reactive protein
(CRP), a marker and product induced by inflammatory
reaction, was confirmed to be the reliable predictor of
ischemic stroke and atherosclerotic CHD by extensive
cohort studies [21,22]. Therefore, the control of local
inflammation by T appears to be important for the pre-
vention of stroke. The effect of fish protein on the inci-
dence of stroke was experimentally first demounted in
SHRSP in the 1970’s [4,15], and the cod protein feeding
was reported to be clinically effective for reducing CRP
in humans [23]. T or sulfur amino acids rich in fish pro-
tein may protect cerebral vessels through its anti-inflam-
matory action by the local formation of T-chloramines.
Consistent with these studies, our world-wide epidemio-
logical study showed that among 5 diet-related factors
T/creatinine (Cr) ratio was proven to be a potent pre-
ventive factor against stroke as well as CHD as men-
tioned later [12].
2) Taurine (T) and lipotoxicity in the vascular wall and
liver
By our further effort for establishing a better model of
atherosclerosis from SHRSP, the selective sib-mating of
the substrain of SHRSP, developing greater reactive
hypercholesterolemia in response to high fat cholesterol
(HFC) diet feeding, was started in 1972 [24]. The strain
developed not only reactive hypercholesterolemia but
also ring-like fat deposits in small mesenteric arteries
within 2 or 3 weeks on HFC diet. This appeared to be a
good model for studying the initial process of fat
Yamori et al. Journal of Biomedical Science 2010, 17(Suppl 1):S6
http://www.jbiomedsci.com/content/17/S1/S6
Page 2 of 14deposition on arterial walls in the development of ather-
osclerosis [25] because similar ring-like fat deposits were
noted at autopsy in the atherosclerotic lesions of cere-
bro-basal arteries in the human brain.
Dietary T supplementation was proven to be effective
for attenuating the development of hypercholesterolemia
and for decreasing fat deposits in the mesenteric arteries
of the selected SHRSP fed on HFC diets [26,27]. Such
cholesterol-lowering effect was also confirmed in volun-
teer medical students who took 6g of T per day for 3
weeks [28]. These beneficial effects of T on hypercholes-
terolemia and arterial fat deposits were experimentally
confirmed to be due to the increased bile acid produc-
tion and the activation of 7a-hydroxylase [26], the rate
limiting enzyme in the process of the conversion of cho-
lesterol into bile acids. This has been proven to be due
to the enhanced gene expression of cholesterol 7a-
hydroxylase [29]. When T feeding lowered cholesterol
levels, the gene expression was proportionally acceler-
ated in relation to the reduced cholesterol level. More-
over, T supplementation was proven to effectively
increase low density lipoprotein (LDL) receptors in the
liver by an experiment of T supplementation accelerat-
ing the decay curve of radio-labeled (125I) LDL [30].
Therefore, cholesterol-lowering mechanisms of T are
summarized to be due to an increase in LDL receptors
and accelerated conversion into bile acids by T, and
other mechanisms such as T’s effect to reduce intestinal
acyl-CoA:cholesterol acyltransferase activity [26,31].
We are presently interested in the activation of LOX-
1, a receptor for oxidized LDL that was up-regulated in
SHRSP fed on HFC diet [32]. T actually decreased arter-
ial fat deposition [26]. Therefore, T is speculated to
attenuate the increase of LOX-1 receptors though a pos-
sible local antioxidant action by T-chloramine formation
[19,31]. The suppressive effect of T on LOX-1 was
noted actually in experimental diabetic or hypertensive
models treated by T [33,34].
In relation to arterial lipid deposition we could estab-
lish a new model for NASH [35], now increasing in
Japan as in other developed countries because of the
westernization of dietary habit to eat more fatty meat
and less fish. The substrain of SHRSP successively bred
by checking greater reactive hypercholesterolemia and
rapid arterial fat deposition for the last 37 years was
named “Arterio-lipidosis prone rats” (ALR, SHRSP 5/
Dmcr) [36]. The recent studies are confirming that ALR
should also be a good model for NASH, developing not
only fatty liver but also inflammatory reaction and active
fibrosis forming pseudo-lobule as well as the typical
morphology of Mallory’s hyaline bodies within 8 to 12
weeks of HFC diet feeding (Figure 1). Dietary T’s effect
in this new model for NASH is expected, because sub-
cutaneously injected T was reported to decrease serum
lipid levels and serum transaminase levels, markers of
hepatocyte damage as well as the biomarkers of oxida-
tive stress in the rats fed on HFC diets developing fatty
liver. Moreover, T suppressed hepatic mRNA expression
of cytokines such as tumor necrosis factor-alpha and
transforming growth factor-beta, possibly involved in
the process of hepatocyte damage and fibrosis, whereas
it increased the expression of a beneficial cytokine, adi-
ponectin. However, the reported models are basically
models for fatty liver and appear morphologically not to
be typical models for NASH in humans as ALR. Since T
supplementation was observed to decrease serum cho-
lesterol levels and arterial fat deposition in ALR [36], if
T could also improve ALR’s typical morphology of
NASH, T would be “a wonderful molecule” for nutri-
tionally protecting CVD risks and NASH, a common
pathology in metabolic syndrome, and would therefore
be expected to contribute to a healthy longevity in man.
In conclusion, our experimental studies consistently
indicate greater prospective for T to contribute to the
nutritional prevention of CHD, as well as stroke and
probably NASH, the increasing health problem of man-
kind exposed to urbanization and westernization of diet-
ary habit and life styles.
3) Taurine (T) and coronary heart diseases (CHD)
3-1) T’s role in CVD prevention
These experimental findings to support the beneficial
effect of T and other nutrients on CVD prevention led
Y. Yamori to propose an international cooperative study
on the association of dietary factors with CVD risks and
CVD mortality in 1982. The protocol of this study
obtained an international consensus of two meetings
organized by WHO-Collaborating Center for Primary
Prevention of CVD in 1983 and 1985 [5-7]. The CAR-
DIAC Study is a multi-center cross sectional epidemio-
logical survey for which about 100 males and 100
females aged 48 to 56 were randomly selected from
each population and invited to participate in a health
examination. This consistedo fw e i g h t ,h e i g h t ,B Pm e a -
surement by an automated BP measurement system,
blood tests for serum total cholesterol (T-Cho) and high
density lipoprotein-cholesterol (HDL), as well as an ana-
lysis of biomarkers (the daily excretions and their ratios
to Cr) of Na, potassium (K) M, T, isoflavones and urea
nitrogen for estimating dietary intakes of salt, vegetables,
milk products, seafood, soybean products and protein by
sampling 24U [5-8,37,38]. The associations of nutrition
with BP and with CVD mortalities were analyzed in
“Core” Study and in “Complete” Study, respectively.
“Core” Study demonstrated that the population averages
of BP, both systolic and diastolic BP (SBP and DBP),
were positively associated with the average population
intake of daily Na estimated by 24U-Na excretion
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were inversely associated with SBP and DBP indicating a
significant association with DBP [7]. “Complete” Study
showed significant positive association of the age-
adjusted mortality rates of stroke with the population
averages of 24U-Na excretion or 24U-Na/K ratio, and
with the arachidonic acid ratio in the plasma phospholi-
pids [8], but the rates were significantly inversely related
with T-Cho. Moreover, CHD mortality rates were signif-
icantly positively related with the population averages of
serum T-Cho and inversely related with polyunsatu-
rated/saturated fatty acid ratios, n-3 fatty acid ratios of
plasma phospholipids or 24U-T, indicating a protective
effect of seafood intake on CHD [8,37].
In CARDIAC Study populations we examined 5 diet-
related markers in relation to CHD by applying the
structural equation modeling for males and females.
Five markers were T-Cho, BMI and Na/Cr, M/Cr
and T/Cr ratios in 24U (Figure 2) [12,38]. The results
clearly indicated that higher T/Cr ratios were highly
significantly related to the risk reduction of CHD both
in males and females, in contrast to T-Cho increasing
the risk. Interestingly, our results first demonstrated M
was also strongly related to the risk reduction following
T. Since M content of seafood is also high, T and M are
positively associated with each other. Twenty-four-hour
U-T excretions were widely distributed in 61 popula-
tions’ averages, positively associated with seafood intakes
and exceptionally high in all Japanese populations eating
fish and seafood daily. With obviously less CHD mortal-
ity rates, Japanese data were excluded from the follow-
ing analyses on the association of CVD risks with
24U-T or -M, and 3960 individuals from 41 WHO-
CARDIAC Study populations were used for the follow-
ing analyses [14].
3-2) Influence of T, M and combined T and M on CVD risks
The mean of the individual data of 24U-T/Cr in 41
populations was 639.4. Individuals with 24U-T/Cr equal
to or above and below the mean are defined as high T
and low T eaters. High T eaters were proven to have
Figure 1 Histopathological hallmarks of ALR fed a high fat and high cholesterol diet. Ten-week-old ALR were fed a high fat and high
cholesterol diet for 8 weeks. (A, B) Fat deposition in the mesenteric artery of ALR was detected by Oil red O staining and observed under low-
and high-power fields. (C, D) Liver fibrosis of ALR was detected by Azan staining and observed under low- and high-power fields.
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index, BMI), both SBP and DBP, T-Cho and atherogenic
index (AI: T-Cho/HDL), an indicator of the risk for
developing atherosclerosis and CHD, than low T eaters
[14]. Similarly, individuals with 24U-M/Cr equal to or
above the mean 82.8 were proven to have significantly
less CVD risks than those with 24U-M/Cr below the
mean [14]. Therefore, we further analyzed these CVD
risks in the individuals with both higher 24U-T/Cr and
-M/Cr (≧ mean) (high T-M excreters) and proved that
they had highly significantly lower BMI, SBP, DBP, TC
and AI than low T-M excreters (< mean) as shown in
Figure 3.
Since the differences in CVD risks between high T-M
excreters and low excreters were statistically so high, we
further analyzed the additional adverse effect of high
salt (Na) intake on low T-M excreters or the additional
beneficial effect of low Na intake on high T-M excreters
(Figure 4). High and low daily T-M excreters were
divided respectively into high and low excreters by the
average of daily salt intake (10.2 g/day) estimated from
24U-Na. Differences in BMI, SBP, DBP and AI, except
for T-Cho, remained statistically significant between
high T-M with low Na excreters and low T-M with
high Na excreters (Figure 4). In contrast to Na intake, K
is regarded to beneficially affect CVD risks, particularly
BP. Therefore, high and low T-M excreters were divided
into high and low K excreters by the average of K/Cr
ratio, 46.1 (Figure 5). Differences in CVD risks except
for T-Cho remained statistically significant between high
K, high T-M excreters and low K, low T-M excreters.
High K and high T-M excreters showed significantly
higher T-Cho than low K and low T-M excreters, indi-
cating dietary habits to take more K linked to the diet
to increase T-Cho higher. Therefore, we can conclude
a l lt h e s eC V Dr i s k s( B M I ,S B P ,D B P ,T - C h o ,A I )a r e
influenced more by differences in high and low T-M
excretion than differences in Na or K excretion regarded
generally as adverse or beneficial dietary factors.
4) Taurine and salt-related hypertension
The population averages of both SBP and DBP in CAR-
DIAC Study showed significantly positive association
with the averages of 24U-Na excretion in males but not
in females in general. The association was significant
only in SBP of postmenopausal women, indicating
gender difference in salt-sensitive BP rise [39]. Since
gene-environmental interactions such as nutrition was
supposed to be involved in the salt sensitively, individual
participants in the CARDIAC health survey were divided
into greater or lesser Na excreters by the mean (10.2 g)
of daily salt intake estimated from 24U-Na excretion. As
shown in Figure 6, greater Na excreters (≧ mean)
showed significantly higher SBP in total and in males
Figure 2 CARDIAC Study results of structural equation modeling of coronary heart diseases (CHD). Hypothetical pathway of 5 diet-
related factors in relation to CHD. T-Cho: total cholesterol, BMI: body mass index (body weight (kg)/height (m)
2), Na/Cr: 24-hour urinary (24U)
sodium (Na, g) to creatinine (Cr, g) ratio, M/Cr = 24U-magnesium (M, mg) to Cr ratio, T/Cr = 24U-taurine (T, mmol) to Cr ratio. Significant
difference: *p < 0.05, **p < 0.01, ***p < 0.001.
Yamori et al. Journal of Biomedical Science 2010, 17(Suppl 1):S6
http://www.jbiomedsci.com/content/17/S1/S6
Page 5 of 14and females, respectively. However, in DBP the differ-
ences in total and males were significant, but there was
no significant difference in females indicating the con-
sistency of the individual data analyses with the popula-
tion average data.
Heart rate (HR) is related to CVD risk in CARDIAC
data [40] as well as in other epidemiological data indi-
cating lower HR is significantly related to longer life-
expectancy in the elderly [41,42]. Since CARDIAC Study
analysis on the population averages showed that higher
24U-T was significantly associated with lower BMI, SBP,
DBP and HR, the involvement of T in salt-sensitive BP
rise was analyzed by dividing greater Na excreters in
males into those with higher HR (≧ mean, 71.5 beat/
min) and with slower HR (< mean). As shown in Figure
7, greater Na excreters with higher HR had significantly
higher SBP and DBP than those with lower HR, indicat-
ing higher HR with higher salt intake estimated by
greater 24U-Na excretion was related with salt-sensitive
BP rise in which sympathetic neural component was
supposedly involved. Therefore, greater 24U-Na
excreters with higher and lower HR were both divided
into high and low T excreters (T/Cr ≧ or < mean).
Higher T excreters’ S B Pa n dD B Pw e r es i g n i f i c a n t l y
lower only in greater Na excreters with high HR, and
there was no significant difference in both SBP and DBP
of greater Na excreters with lower HR. These findings
are suggestive of T’s BP reducing effect on neural regu-
lation of BP rise induced by salt loading as in experi-
mental studies in rat models of salt-sensitive
hypertension, SHRSP and DOCA salt hypertensive rats.
T administration decreased BP more markedly in salt-
sensitive SHRSP than in SHR and in normotensive Wis-
ter-Kyoto rats [9], and in salt-loaded DOCA hyperten-
sive rats in which T reduced BP increase as well as
catecholamine excretion [43]. The latter indicates the
neurogenic development of salt-induced hypertension.
We previously reported that BP and catecholamine
responses to cold exposure stress in young volunteers
were significantly greater in those with family history of
hypertension than the other without the family history
[15,44]. Therefore, our present epidemiological data
Figure 3 Cardiovascular risks in higher taurine-magnesium (T-M) excreters and lower T-M excreters. T/Cr = 24-hour urinary (24U) taurine
(T, mmol) to creatinine (Cr, g) ratio, M/Cr = 24U-magnesium (M, mg) to Cr ratio. T/Cr: + ≧ mean (= 639.4), - < mean, M/Cr: + ≧ mean (= 82.8), -
< mean. BMI: body mass index (body weight (kg)/height (m)
2), SBP: systolic blood pressure, DBP: diastolic blood pressure, T-Cho: total
cholesterol, AI: atherogenic index (T-Cho/high density lipoprotein cholesterol). Parenthesis indicates a number of participants. Significant
difference: ***p < 0.001.
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HR, higher T excreters showed lower BP than lower T
excreters support the possible neurogenic component
modulated by T in the salt sensitive hypertension.
5) Taurine (T) and magnesium (M) in high and low risk
populations
Since the individuals with greater T and M intakes esti-
mated from 24U excretions had significantly lower CVD
risks than lesser T and M excreters [14], typical popula-
tions, in which the population averages of both 24U-T
and -M were higher and lower than the average of
CARDIAC population samples, were investigated for
their life style and dietary habits for comparison.
Among 41 WHO-CARDIAC populations, Guiyang peo-
ple in south-west China near Guangzhou showed both
higher 24U-T and -M than the averages among total
CARDIAC populations (Figure 8) [38]. In contrast, St.
John’s population living on Newfoundland Island,
Canada had both lower T and M than the averages of
the CARDIAC populations. In Guiyang we first carried
out a health survey in 1988 and repeated the survey in
1997 after the rapid economic development in China
[38]. There lived Miao, Pui and other minority people
who were still keeping a traditional dietary habit, such
as eating daily soy beans and various soy products,
baked bean curd (coagulated soy protein) prepared by
M-rich water and eating much fresh water fish, indicat-
ing that their rich sources of T and M are fresh water
fish, soy and soy products. The prevalence of CVD risks
was remarkably low in Guiyang, and they had almost no
risks of obesity, hypertension and hypercholesterolemia
indicating that their dietary habit of consuming high
levels of both T and M is ideal for CVD prevention (Fig-
ure 9). Correspondingly, the Guiyang population had
significantly lower BMI, both SBP and DBP, T-Cho level
and AI than the averages of CARDIAC populations tak-
ing various amounts of T and M in other parts of the
world. In contrast, Newfoundlanders in St. John’sw e r e
the descendants of Scottish and Irish immigrants and
were engaged in farming sheep on the island and also in
fishing for abundant sea water fish near the island. They
traditionally salted fresh fish in barrels for shipping
them as preserved food to Canada and US, and did not
eat raw fish like the Japanese. They were eating mainly
meat products so that their T and M excretions were
lower than the averages of CARDIAC populations. CVD
risks of Newfoundlanders both in male and females
Figure 4 Cardiovascular disease risks in higher and lower taurine-magnesium excreters with greater or lesser sodium excretion. T/Cr =
24-hour urinary (24U) taurine (T, mmol) to creatinine (Cr, g) ratio, M/Cr = 24U-magnesium (M, mg) to Cr ratio, Na: 24U-sodium (Na as NaCl, g/
day). T/Cr: + ≧ mean (= 639.4), - < mean, M/Cr: + ≧ mean (= 82.8), - < mean, Na: + ≧ mean (= 10.14), - < mean. BMI: body mass index (body
weight (kg)/height (m)
2), SBP: systolic blood pressure, DBP: diastolic blood pressure, T-Cho: total cholesterol, AI: atherogenic index (T-Cho/high
density lipoprotein cholesterol). Parenthesis indicates a number of participants. Significant difference: ***p < 0.001.
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hour urinary (24U) taurine (T, mmol) to creatinine (Cr, g) ratio, M/Cr: 24U-magnesium (M, mg) to Cr ratio, K/Cr: 24U-potassium (K, milliequivalent)
to Cr ratio. T/Cr: + ≧ mean (= 639.4), - < mean, M/Cr: + ≧ mean (= 82.8), - < mean, K/Cr: + ≧ mean (= 46.1), - < mean. BMI: body mass index
(body weight (kg)/height (m)
2), SBP: systolic blood pressure, DBP: diastolic blood pressure, T-Cho: Total Cholesterol, AI: Atherogenic index (Total
cholesterol/HDL cholesterol). Parenthesis indicates a number of participants. Significant difference: *p < 0.05, ***p < 0.001.
Figure 6 Blood pressure in greater or lesser 24-hour urinary sodium. Na: 24-hour urinary (24U) sodium (Na as NaCl, g/day), Na: + ≧ mean
(= 10.14), - < mean. SBP: systolic blood pressure, DBP: diastolic blood pressure. Parenthesis indicates a number of participants. Significant
difference: **p < 0.01, ***p < 0.001.
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ple who were consuming high levels of both T and M
(Figure 9). St. John’s population was known for their
high CVD mortality rates, whereas Guiyang’s population
was known for their low CVD mortality rates and their
longevity in China. These data based on the individual
biomarkers related to T and M intakes indicate that eat-
ing foods containing both T and M is good for the phy-
siological regulation of the homeostasis of the cells and
human bodies. This dietary habit may contribute to the
prevention of CVD and thus to the healthy longevity of
humans. CVD risks are definitely lower in individuals
excreting high levels of 24U-T and -M. Among CAR-
DIAC populations, Guiyang population excreting and
supposedly taking both had definitely less CVD risks
than the St. John’s population who were not excreting
and taking both elements. Therefore, seafood, soy, nuts,
and milk taken regularly as the sources of T and M
could be recommended for CVD prevention.
6) Bush food rich in T and M, needed for health
We are still continuing our CARDIAC health examina-
tion since we started the world wide study in 1985 in
coordination with WHO. Our recent study on Austra-
lian Aboriginal people for over past 7 years demon-
strated that they are presently suffering most severely
from lifestyle-related diseases in comparison with the
other CARDIAC populations [38,45]. Obesity, hyperten-
sion and diabetes in Aboriginals start 20 to 30 years
younger than other Australian and Japanese people (Fig-
ure 10) [45]. When they lost bush food, their M intake
was greatly decreased because bush food consisting of
nuts, seeds, grains, beans, fruits and seaweeds contains
much M (Figure 11). Aboriginals living near the coast of
the state of Victoria used to utilize various foods from
the sea and fresh water. Aboriginals living in Framling-
ham, Victoria were known to start the culture of eels
8,000 years ago and there were several large shell
mounds, the piling up of various shells like mountains
at the sea side not far from Melbourne, indicating that
Aboriginals’ life had been highly dependent on their
bush food as well as on the seafood, both the richest
sources of T and M. Before the colonials were estab-
lished, their daily foods were clams, various shells and
fish containing a large amount of T (Figure 12), and
also their traditional smoked eels, which were a rich
source of T and DHA and eaten as their common pre-
served food. As hunters and food gatherers, Aboriginals,
according to the 2-week food intake analysis report,
were supposed to live by taking their energy, for exam-
ple, 34% from complex carbohydrates, 13% from fat and
53% from protein [46]. Although we do not know
exactly what they ate, we tentatively suppose, for exam-
ple, they ate 400 g of yam, 300 g of frogs, 5 g of
almonds, 140 g of bream, 200 g of clams, 300 g of snails.
These foods contain about 100 g of carbohydrates, 15 g
of fat and 170 g of protein and correspond roughly to
1300 kcal/day. The daily intake of T and M from these
Figure 7 Effect of taurine on blood pressure in male greater salt eaters with faster heart rate. Male greater salt eaters were defined as
shown in Figure 6 and analyzed only in those whose heart rate (HR) were recorded. T/Cr: 24-hour urinary taurine (T, mmol) to creatinine (Cr, g)
ratio. T/Cr: + ≧ mean (= 639.4), - < mean, HR: + ≧ mean (= 72.9), - < mean. SBP: systolic blood pressure, DBP: diastolic blood pressure.
Parenthesis indicates a number of participants. Significant difference: *p < 0.05, **p < 0.01, ***p < 0.001.
Yamori et al. Journal of Biomedical Science 2010, 17(Suppl 1):S6
http://www.jbiomedsci.com/content/17/S1/S6
Page 9 of 14Figure 8 Food culture, lifestyle and topographic background of Guiyang people in China.
Figure 9 Prevalence of risk of lifestyle-related diseases in populations excreting higher and lower taurine-magnesium. Obesity: BMI
(body mass index, (kg)/height (m)
2) ≧ 30, Hypertension: systolic blood pressure ≧ 140 mmHg and/or diastolic blood pressure ≧ 90 mmHg,
Hypercholesterolemia: total cholesterol ≧ 220mg/dl. Significant difference: *p < 0.05, **p < 0.01, ***p < 0.001.
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Page 10 of 14foods is about 3200 mg and 640 mg, respectively, both
being far higher than the average of CARDIAC popula-
tions in the world.
Moreover, they had no salt at all before Captain
Cock reached Australia at the beginning of 18th cen-
tury. Our CARDIAC data help us to speculate how
Aboriginals should have been free from CVD risks,
based on our comparison of CARDIAC Study indivi-
duals consuming a high amount of T and M but less
Na with those consuming less T and M but a great
amount of Na. CVD risks were clearly and highly sig-
nificantly lower in the CARDIAC Study participants
t a k i n gah i g ha m o u n to fTa n dMb u tl e s sN a ,c o r r e -
sponding to the nutritional balance of Aboriginal
ancestors eating traditional bush food. High T and M
but less Na-containing foods were supposed to be
taken commonly by the ancestors of humans living on
hunter-gatherers’ foods like Aboriginal ancestors for
nearly 10 times longer than the period after the start
of agriculture and farming. Therefore, these dietary
Figure 10 Prevalence of hypertension and hypercholesterolemia. Hypertension: systolic blood pressure ≧ 140 mmHg and/or diastolic blood
pressure ≧ 90 mmHg, hypercholesterolemia: total cholesterol ≧ 220mg/dl.
Figure 11 Magnesium contents of typical dry food.
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Page 11 of 14conditions seem to be more suitable for the human
genome to live a healthy life without CVD.
7) T and M in cardiovascular pathophysiology and
longevity
Both T and M are basically important for the mainte-
nance of life. T is involved in cellular physiology by its
effect on osmoregulation, anti-oxidant, membrane stabi-
lization and calcium regulation [47-49], and also on
lipid metabolism related to dyslipidemia and athero-
sclerosis through its role in bile acid conjugation
[47,48]. Recently, T-conjugated endogenous bile acid
derivative, ursodeoxycholic acid was focused on as a
chemical chaperone which was proven to reduce endo-
plasmic reticulum (ER) stress and restore glucose home-
ostasis in a mouse model of type 2 diabetes [50]. The
alleviation of ER-stress may restore insulin sensitivity in
the liver, muscle and adipose tissue, thus contributing to
the resolution of fatty liver diseases, diabetes and obe-
sity. High dietary T administration was proven to reduce
apoptosis and atherosclerosis possibly via normalization
of ER stress [51].
Moreover, in relation to the ageing of vascular tissue
and the accelerated senescence of endothelial progenitor
cell (EPC) noted in SHRSP [52], T was reported to
attenuate EPC senescence in SHRSP and to modulate
clinically the deterioration of endothelial function in
smokers [53-55]. These classical and new concepts of
the pathophysiological roles of T suggest that a high T
intake may contribute to longevity through CVD health
and lifestyle-related diseases.
On the other hand, M is the 8th abundant element in
the weight, the number of atoms and the volume per-
centage of all atoms on the earth. It is also the most
abundant intracellular divalent cation and is involved in
the various biological functions of about 300 enzymes as
their coenzyme. They include all enzymatic reactions
requiring ATP, such as Na-K ATPase, important for
intracellular ionic balance. Therefore, M is supposed to
be causatively and clinically related to cardiovascular
health, hypertension and diabetes [56-58]. Lowering of
intracellular free M was observed in SHRSP in the pro-
cess of aging and development of hypertension [59].
Dietary M supplementation increased intralymphocytic
free M and attenuated the grade of hypertension [60].
These experimental findings were recently confirmed
clinically in patients with mild hypertension whose
ambulatory BP was significantly decreased concomi-
tantly with the increased intracellular free M and K, and
decreased intracellular free Ca and Na, by the dietary
supplementation of 600 mg of pidolate M [61]. In this
clinical experiment, M supplementation increased serum
M and 24U excretion of M. Therefore, the aforemen-
tioned epidemiologically observed 24U-M excretion was
regarded to correspond to dietary M intake. M was also
reported to decrease BP by inhibiting sympathetic nerve
by blocking N-type Ca channels [62].
Since the evolutional origin of life of human beings
was inside the sea containing abundant M and food
gatherers lived on seafood rich in T, both M and T are
assumed to be essential for the homeostasis maintaining
cardiovascular health.
Figure 12 Taurine contents of typical food.
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In addition to the pathophysiological and various phy-
siological functions of T, the preventive effect of T was
first experimentally demonstrated in hypertensive rat
models, SHR and SHRSP developing hypertension and
stroke genetically. World-wide epidemiological studies
conducted for the last 25 years revealed that 24U-T was
inversely associated with the age-adjusted mortality rates
of stroke and CHD. High 24U-T, particularly combined
with high M excretion, was associated highly signifi-
cantly with lower CVD risks, obesity, hypertension,
hypercholesterolemia and AI. These findings indicate
the consistency of the beneficial T effects on animal
models and humans proven either experimentally or
epidemiologically. Such consistency of the extensive
basic and epidemiological findings of T effects and the
effects combined with M indicates greater prospective
for T to contribute to the nutritional prevention of
CVD and lifestyle-related diseases.
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